It's not a bear raid. The market doesn't believe ACST's lead compound will be much of a money maker, and if it is, that is years away.
MNKD is garbage. If you think it's a golden ticket, you're going to be greatly disappointed. There are dozens and dozens of better biotechs out there.
TKMR investors really should pay attention to this. If the HIV drug is proven effective, it's going to kill the Ebola trade here. Yes, they still have Hep B, which is the big moneymaker, but the market makers will spank this stock if Ebola is treatable with the HIV drug.
Sell the news. Everybody expected this outcome. The fact that there was only a small volume increase over the past month was an indicator that this was going to happen.
I don't think the shorts are nervously eyeing any exits. If they were, the short interest wouldn't keep going up. The shorts believe SRPT is doomed and won't be granted AA. Longs would do best to accept that. I'm a long because I think the shorts are wrong, but until an Advisory Committee gives its overwhelming support, shorts won't be going anywhere, and even then, I'm not sure they will. Let's be realistic here.
Your research says this every day, and every day nothing occurs. Throw enough darts at a dartboard and eventually you'll hit a bullseye, I suppose.
Someone knows something? Uh, have you paid attention to the market this week? It's gotten killed.
Just put the bashers on ignore. Your calls have been good. Keep sharing them and don't give the bashers the power to tick you off. You don't have to explain yourself to them. It's not worth your time.
For future reference, they don't halt stocks for news conferences, and it is at the company's discretion to halt a stock.
Yep, and you think pharmas shouldn't be working on a vaccine? That makes absolutely no sense. If 1,000,000 become infected, it becomes an extreme, undeniable concern for the entire globe. We should spend as much time/money trying to prevent as we should trying to treat. Unless your only objective is to make money on drugs attempting to treat those already infected.
Don't be silly, gary. There's no risk in trying to make a vaccine at the same time as testing experimental drugs. If Ebola deaths explode into the millions, we'd sure as heck better hope a vaccine is already in the works. I'm sure most folks would prefer a vaccine to prevent Ebola to taking an experimental drug after being infected first.
Um, duh. All one has to do is look at the daily chart to have figured that out. The stock rises quickly, then falls quickly. Overall, the daily chart is VERY BULLISH. But I'm sure you'll try to convince folks that it isn't. This drop was to be expected.
Correct. Profit taking. Usually happens after people pump incessantly like crazy, and you can be sure a ton of those same pumpers are the ones taking profit right now. BUYOUT BUYOUT BUYOUT!!! It ain't coming, but the stock will do fine anyway.
I doubt it is the most effective if you are going to use the research from the chimpanzees. TKMR's drug had a 100% effectiveness rate. That can't be beat.
Spot on, easy. The Ebola program should be partnered, even if it doesn't make a ton of money for the company. Get a large pharma that can manufacture the drug on board and handle the everyday details. I'm starting to wonder if the Ebola issue is messing with the DMD timelines.